Sökresultat

RIFM fragrance ingredient safety assessment, 1-oxaspiro[4.5]decan-2-one, 8-ethyl-, trans-, CAS Registry Number 91069-40-8

RIFM fragrance ingredient safety assessment, 4-methylnonanoic acid, CAS Registry Number 45019-28-1

RIFM fragrance ingredient safety assessment, guaiyl acetate, CAS Registry Number 134-28-1

RIFM fragrance ingredient safety assessment, 2-methylbutyl acetate, CAS Registry Number 624-41-9

Normer i arbetet med unga asylsökande : - om "svenskhet" och föreställningar om etnicitet, kultur, ålder och kön i den tidiga integrationsprocessen

I Helsingborgs stad genomfördes 2016 till 2017 ett projekt som syftade till att förbättra samverkan mellan skola och HVB-hem för att gynna integrationsarbetet.Integration ska, enligt svensk politik, kännetecknas av invandrares och flyktingars rätt till välfärdstjänster. Personer som kommer som invandrare eller flyktingar har också rätt att bejaka och uttrycka sin egen kulturella identitet och ska

RIFM fragrance ingredient safety assessment, 4-hexen-1-ol, 5-methyl-2-(1-methylethenyl)-, CAS Registry Number 58461-27-1

RIFM fragrance ingredient safety assessment, pentyl benzoate, CAS Registry Number 2049-96-9

Interspecific transfer of parasites following a range-shift in Ficedula flycatchers

Human-induced climate change is expected to cause major biotic changes in species distributions and thereby including escalation of novel host-parasite associations. Closely related host species that come into secondary contact are especially likely to exchange parasites and pathogens. Both the Enemy Release Hypothesis (where invading hosts escape their original parasites) and the Novel Weapon Hyp

Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease

Background: Little research has been conducted regarding the relationship between sleep disorders and different pain types in Parkinson's disease (PD). Objective: To explore the influence of the various pain subtypes experienced by PD patients on sleep. Methods: Three hundred consecutive PD patients were assessed with the PD Sleep Scale-Version 2 (PDSS-2), King's PD Pain Scale (KPPS), King's PD Pa

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

Breast cancer patients with BRCA1/2-driven tumors may benefit from targeted therapy. It is not clear whether current BRCA screening guidelines are effective at identifying these patients. The purpose of our study was to evaluate the prevalence of inherited BRCA1/2 pathogenic variants in a large, clinically representative breast cancer cohort and to estimate the proportion of BRCA1/2 carriers not d

RIFM fragrance ingredient safety assessment, isononyl acetate (isomer unspecified), CAS Registry Number 40379-24-6

RIFM fragrance ingredient safety assessment, citronellyl phenylacetate, CAS Registry Number 139-70-8

RIFM fragrance ingredient safety assessment, ethyl trans-2-butenoate, CAS Registry Number 623-70-1

RIFM fragrance ingredient safety assessment, ethyl 2-methylbutyrate, CAS Registry Number 7452-79-1

RIFM fragrance ingredient safety assessment, 2-methylbutyl butyrate, CAS Registry Number 51115-64-1

RIFM fragrance ingredient safety assessment, methyl isovalerate, CAS Registry Number 556-24-1

RIFM fragrance ingredient safety assessment, butyl benzoate, CAS registry number 136-60-7

RIFM fragrance ingredient safety assessment, octahydro-4,7-methano-1H-indenemethyl formate, CAS Registry Number 68039-78-1

Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO

Background: Portal vein occlusion (PVO) is an established method to increase the volume of the future liver remnant (FLR). The main reasons for not proceeding to radical hepatectomy are lack of volume increase and tumor progression due to a wait-time interval of up to 8 weeks. The hypothesis was that the increase in FLR volume is not linear and is largest during the first weeks. Methods: Patients

Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis

Background: Aortic valve stenosis (AVS) and coronary artery disease (CAD) have a significant genetic contribution and commonly co-exist. To compare and contrast genetic determinants of the two diseases, we investigated associations of the LPA and 9p21 loci, i.e. the two strongest CAD risk loci, with risk of AVS. Methods: We genotyped the CAD-associated variants at the LPA (rs10455872) and 9p21 loc